The Science, Technology and Research partnership (STAR), Clinical Research Network (CRN) is a member of a National Patient-Centered Clinical Research Network, PCORnet. Our network encompasses 10 health systems, and our work is focused on research to improve health by supporting comparative effectiveness studies, pragmatic clinical trials, health system innovation, and the other research needs of our partners.

Do you want to...

Request more information?

Collaborate with STAR CRN?

Patients in the CDM
Unique Encounters
Project Requests to Date

Latest news

Stanford, Essentia Health join VUMC-based clinical research network. 

The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.

VUMC Receives $28 million to lead national study of COVID-diabetes link (CODA)

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study the relationship between COVID-19 and diabetes.

VUMC receives $7 million award from PCORI to compare breathing tube sedation.
Vanderbilt University Medical Center has received a $7 million, five-year funding award from PCORI (Patient-Centered Outcomes Research Institute) to compare two sedatives used to place breathing tubes in the emergency department (ED) or intensive care unit (ICU).
STAR Quarterly Update 

STAR CRN is happy to announce our upcoming Quarterly Update on April 25, 2024, at 1 pm CST.

PREVENTABLE is one of the largest research studies in older adults. The purpose is to learn if taking a statin could help older adults live well for longer by preventing dementia, disability, or heart disease. A statin is a commonly used drug to lower cholesterol.

Are you a good fit for PREVENTABLE?

Contact study team for more information.

The PRECIDENTD study is designed to learn more about the only two classes of diabetes medication shown to reduce the risk of heart disease for people with type 2 diabetes. The goal is to learn which class of medication works better, or if taking both classes together works better than taking just one.

To learn more please visit:  or Contact study team for more information.